{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:07:22Z","timestamp":1761664042854},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"AstraZeneca NIGERIA","award":["ASTRAZENECA SOUTH AFRICA"],"award-info":[{"award-number":["ASTRAZENECA SOUTH AFRICA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The prevalence of gastroesophageal reflux disease (GERD) in Africa is not known but is believed to be increasing because of demographic and epidemiologic transition. The main objectives of this study were to determine the prevalence and risk factors of GERD, and its degree of overlap with dyspepsia and irritable bowel syndrome (IBS) in Nigeria, a typical African population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was an observational, cross-sectional and descriptive study of adult Nigerians. Diagnosis of GERD was by means of the gastroesophageal reflux disease questionnaire (GERDQ) while the diagnosis of dyspepsia and IBS was based on the Rome III criteria for the diagnosis of functional gastrointestinal disorders. The GERDQ and Rome III questionnaires for dyspepsia and IBS were merged into a composite questionnaire and administered to the study participants who were recruited with a multi-stage sampling technique.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Out of 3520 subjects who participated in the study across the country, 269 (7.6%) satisfied the diagnostic criteria for GERD, while 107 (3.0%) had GERD associated with significant impairment of quality of life. Risk factors of GERD (represented by odds ratios) were age 1.014(95% CI: 1.006\u20131.022), use of analgesics 1.461 (95% CI: 1.060\u20132.025), and use of herbs 1.318 (95% CI: 1.020\u20131.704). Overlap of GERD with dyspepsia and\/or IBS was observed in over 50% of cases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The prevalence of GERD in this study is 7.6%. Age, use of analgesics and use of herbs increase the risk, albeit minimally. A high degree of overlap with dyspepsia and IBS exists in Nigerian patients with GERD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-020-01261-8","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T10:03:05Z","timestamp":1586944985000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Gastroesophageal reflux disease in a typical African population: a symptom-based multicenter study"],"prefix":"10.1186","volume":"20","author":[{"given":"Sylvester Chuks","family":"Nwokediuko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olusegun","family":"Adekanle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adegboyega","family":"Akere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulfatai","family":"Olokoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiedozie","family":"Anyanechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabo Mustapha","family":"Umar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abubakar","family":"Maiyaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uchenna","family":"Ijoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olive","family":"Obienu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augustine","family":"Uhunmwangho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Ndububa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,15]]},"reference":[{"key":"1261_CR1","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","volume":"101","author":"N Vakil","year":"2006","unstructured":"Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus Group. The Montreal definition and classification of gastroesphageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900\u201320.","journal-title":"Am J Gastroenterol"},{"key":"1261_CR2","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1055\/s-2007-963628","volume":"45","author":"R Fass","year":"2007","unstructured":"Fass R. Non-erosive reflux disease (NERD) and erosive esophagitis: a spectrum of disease or special entities? Z Gastroenterol. 2007;45:1156\u201363.","journal-title":"Z Gastroenterol"},{"key":"1261_CR3","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1001\/jama.295.13.1566","volume":"295","author":"P Moayyedi","year":"2006","unstructured":"Moayyedi P, Talley NJ, Fennerty MB, Vakil N. Can the clinical history distinguish between organic and functional dyspepsia? JAMA. 2006;295:1566\u201376.","journal-title":"JAMA"},{"key":"1261_CR4","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.cgh.2017.03.021","volume":"15","author":"MF Vaezi","year":"2017","unstructured":"Vaezi MF, Pandolfino JE, Vela MF, Shaheen NJ. White paper AGA: Optimal strategies to define and diagnose gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2017;15:1162\u201372.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1261_CR5","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1053\/j.gastro.2008.08.044","volume":"135","author":"PJ Kahrilas","year":"2008","unstructured":"Kahrilas PJ, Shaheen NJ, Vaezi MF. American gastroenterological association institute technical review on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135:1392\u2013413.","journal-title":"Gastroenterology"},{"key":"1261_CR6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ajg.2012.444","volume":"108","author":"PO Katz","year":"2013","unstructured":"Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Qastroenterol. 2013;108:308\u201328.","journal-title":"Am J Qastroenterol"},{"key":"1261_CR7","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","volume":"63","author":"HB El-Serag","year":"2014","unstructured":"El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastroesophageal reflux disease: a systematic review. Gut. 2014;63:871\u201380.","journal-title":"Gut"},{"key":"1261_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1136\/gutjnl-2016-313589","volume":"67","author":"LH Eusebi","year":"2018","unstructured":"Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran R, Bazzoli F, Ford AC. Global prevalence of and risk factors for gastroesophageal reflux symptoms: a meta-analysis. Gut. 2018;67:430\u201340.","journal-title":"Gut"},{"key":"1261_CR9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1046\/j.1365-2036.2003.01737.x","volume":"18","author":"W Wong","year":"2003","unstructured":"Wong W, Lai K, Lam K, Hui WM, Hu WH, Lam CL, et al. Prevalence, clinical spectrum and healthcare utilization of gastroesophageal reflux disease in a Chinese population: a population-based study. Aliment Pharmacol Ther. 2003;18:595\u2013604.","journal-title":"Aliment Pharmacol Ther"},{"key":"1261_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/CEG.S103485","volume":"9","author":"N Spantideas","year":"2016","unstructured":"Spantideas N, Drosou E, Bougea A, Assimakopoulos D. Gastroesophageal reflux disease symptoms in the Greek general population: prevalence and risk factors. Clin Exp Gastroenterol. 2016;9:143\u20139.","journal-title":"Clin Exp Gastroenterol"},{"key":"1261_CR11","first-page":"289","volume":"10","author":"M Nouraie","year":"2007","unstructured":"Nouraie M, Razjouyan H, Assady M, Malekzadeh R, Nasseri-Moghaddam S. Arch Iran Med. 2007;10:289\u201394.","journal-title":"Arch Iran Med"},{"key":"1261_CR12","doi-asserted-by":"crossref","unstructured":"Nouraie M, Radmard AR, Zaer-Rezaii H, Razjouyan H, Nassaeri-Moghaddam S, Malekzadeh R. Hygiene could affect GERD prevalence independently: a population-based study in Tehran. Am J Gastroenterol. 2007;102:1353\u201360.","DOI":"10.1111\/j.1572-0241.2007.01208.x"},{"issue":"Suppl1","key":"1261_CR13","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.5152\/tjg.2017.01","volume":"28","author":"S Bor","year":"2017","unstructured":"Bor S. Consensus report on gastroesophageal reflux disease in Turkey. Turk J Gastroenterol. 2017;28(Suppl1):S1\u20132.","journal-title":"Turk J Gastroenterol"},{"key":"1261_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.14740\/jocmr3292w","volume":"10","author":"OB Asuwat","year":"2018","unstructured":"Asuwat OB, Alzahrani AA, Alzhrani MA, Alkhathami AM, Mahfouz MEM. Prevalence of gastroesophageal reflux disease in Saudi Arabia. J Clin Med Res. 2018;10:221\u20135.","journal-title":"J Clin Med Res"},{"key":"1261_CR15","unstructured":"Hunt R, Armstrong D, Kateralis P, Afihene M, Bane A, Bhatia S, et al. WGO Global Guidelines: GERD- Global Perspective on Gastroesophageal Reflux Disease. J Clin Gastroenterol. 201751:467\u201378."},{"key":"1261_CR16","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.3748\/wjg.v25.i25.3183","volume":"25","author":"S Smith","year":"2019","unstructured":"Smith S, Fowara M, Pellicano R. Infections with helicobacter pylori and challenges encountered in Africa. World J Gastroenterol. 2019;25:3183\u201395.","journal-title":"World J Gastroenterol"},{"key":"1261_CR17","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/j.1365-2036.2009.04142.x","volume":"30","author":"R Jones","year":"2009","unstructured":"Jones R, Junghard O, Dent J, Vakil N, Halling K, Wernersson B, et al. Development of the GERDQ, a tool for the diagnosis and management of gastroesophageal reflux disease in primary care. Aliment Pharmacol Ther. 2009;30:1030\u20138.","journal-title":"Aliment Pharmacol Ther"},{"key":"1261_CR18","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","volume":"130","author":"DA Drossman","year":"2006","unstructured":"Drossman DA. The functional gastrointestinal disorders and the Rome III process, appendix a. Gastroenterology. 2006;130:1377\u201390.","journal-title":"Gastroenterology"},{"key":"1261_CR19","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","volume":"153","author":"JKY Hooi","year":"2017","unstructured":"Hooi JKY, Lai WY, Ng WK, Seun MMY, Underwood FE, Tanyingoh D, et al. Global prevalence of helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153:420\u20139.","journal-title":"Gastroenterology"},{"key":"1261_CR20","doi-asserted-by":"publisher","first-page":"985249","DOI":"10.1155\/2015\/985249","volume":"2015","author":"SJ Hong","year":"2015","unstructured":"Hong SJ, Kim SW. Helicobacter pylori infection in gastroesophageal reflux disease in the Asian countries. Gastroenterol Res Pract. 2015;2015:985249.","journal-title":"Gastroenterol Res Pract"},{"key":"1261_CR21","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1523-5378.2008.00624.x","volume":"13","author":"D Corley","year":"2008","unstructured":"Corley D, Hawkey G, Greenwood D, et al. Helicobacter pylori and gastroesophageal reflux disease: a community-based study. Helicobacter. 2008;13:352\u201360.","journal-title":"Helicobacter"},{"key":"1261_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1046\/j.1365-2036.1999.00460.x","volume":"13","author":"HJ O\u2019Connor","year":"1999","unstructured":"O\u2019Connor HJ. Review article: helicobacter pylori and gastroesophageal reflux disease-clinical implications and management. Aliment Pharmacol Ther. 1999;13:117\u201327.","journal-title":"Aliment Pharmacol Ther"},{"key":"1261_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1523-5378.2007.00466.x","volume":"12","author":"H Nordenstedt","year":"2007","unstructured":"Nordenstedt H, Nilsson M, Johnsen R, Lagergren J, Hveen K. Helicobacter pylori infection and gastroesophageal reflux in a population-based study (the HUNT study). Helicobacter. 2007;12:16\u201322.","journal-title":"Helicobacter"},{"key":"1261_CR24","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/ajg.2009.734","volume":"105","author":"M Yaghoobi","year":"2010","unstructured":"Yaghoobi M, Farrokhyar F, Yuan Y, Hunt RH. Is there an increased risk of GERD after helicobacter pylori eradication? : A meta-analysis. Am J Gastroenterol. 2010;105:1007\u201313.","journal-title":"Am J Gastroenterol"},{"key":"1261_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1523-5378.2011.00846.x","volume":"16","author":"B Qian","year":"2011","unstructured":"Qian B, Ma S, Shang L, Qian J, Zhang G. Effects of helicobacter pylori eradication on gastroesophageal reflux disease. Helicobacter. 2011;16:255\u201365.","journal-title":"Helicobacter"},{"key":"1261_CR26","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s10620-008-0413-9","volume":"53","author":"H El-Serag","year":"2008","unstructured":"El-Serag H. The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci. 2008;53:2307\u201312.","journal-title":"Dig Dis Sci"},{"key":"1261_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/DMSO.S38626","volume":"6","author":"II Chukwuonye","year":"2013","unstructured":"Chukwuonye II, Chuku A, John C. Prevalence of overweight and obesity in adult Nigerians-a systematic review. Diabetes, Metab Syndr and Obes. 2013;6:43\u20137.","journal-title":"Diabetes, Metab Syndr and Obes"},{"key":"1261_CR28","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.cgh.2007.08.011","volume":"5","author":"J Lee","year":"2007","unstructured":"Lee J, Anggiansah A, Anggiansah R, Young A, Wong T, Fox M. Effects of age on the gastroesophageal junction, esophageal motility, and reflux disease. Clin Gastroenterol Hepatol. 2007;5:1392\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1261_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1572-0241.2003.07188.x","volume":"98","author":"AC Achem","year":"2003","unstructured":"Achem AC, Achem SR, Stark ME, DeVault KR. Failure of esophageal peristalsis in older patients: association with esophageal acid exposure. Am J Gastroenterol. 2003;98:35\u20139.","journal-title":"Am J Gastroenterol"},{"key":"1261_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/dote\/11.2.106","volume":"11","author":"RB Ter","year":"1998","unstructured":"Ter RB, Johnston BT, Castell DO. Influence of age and gender on gastroesophageal reflux in symptomatic patients. Dis Esophagus. 1998;11:106\u20138.","journal-title":"Dis Esophagus"},{"key":"1261_CR31","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1365-2036.2010.04542.x","volume":"33","author":"A Becher","year":"2011","unstructured":"Becher A, Dent J. Systematic review: ageing and gastro-oesophageal reflux disease symptoms, oesophageal function and reflux oesophagitis. Aliment Pharmacol Ther. 2011;33:442\u201354.","journal-title":"Aliment Pharmacol Ther"},{"key":"1261_CR32","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1136\/gutjnl-2016-313589","volume":"67","author":"LH Eusebi","year":"2018","unstructured":"Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford AC. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut. 2018;67:430\u201340.","journal-title":"Gut."},{"issue":"13","key":"1261_CR33","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1097\/CM9.0000000000000275","volume":"132","author":"W Kun","year":"2019","unstructured":"Kun W, Li Z, Zhong-Hu H, Zuo-Jing L, Lu Z, Nan H, et al. A population-based survey of gastroesophageal reflux disease in a region with high prevalence of esophageal cancer in China. Chin Med J. 2019;132(13):1516\u201323.","journal-title":"Chin Med J"},{"key":"1261_CR34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/nyas.13196","volume":"1380","author":"M Bashashati","year":"2016","unstructured":"Bashashati M, Sarosiek I, McCallum RW. The epidemiology and mechanisms of gastroesophageal reflux disease in the elderly: a perspective. Ann N Y Acad Sci. 2016;1380:230\u20134.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"1261_CR35","doi-asserted-by":"publisher","first-page":"559","DOI":"10.5056\/jnm18140","volume":"24","author":"T Yamasaki","year":"2018","unstructured":"Yamasaki T, Hemond C, Eisa M, Ganocy S, Fass R. The changing epidemiology of gastroesophageal reflux disease: are patients getting younger? J Neurogastroenterol Motil. 2018;24(4):559\u201369.","journal-title":"J Neurogastroenterol Motil"},{"key":"1261_CR36","doi-asserted-by":"publisher","unstructured":"Essan DT, Fasoro AA, Odesanya OE, Esan TO, Ojo EF, Faeji CO. Assessment of self-medication practices and its associated factors among undergraduates of a private University in Nigeria. J Environ Public Health. 2018. https:\/\/doi.org\/10.1155\/2018\/5439079.","DOI":"10.1155\/2018\/5439079"},{"issue":"3","key":"1261_CR37","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.4314\/tjpr.v7i3.14685","volume":"7","author":"S Awofisayo","year":"2008","unstructured":"Awofisayo S, Awofisayo O, Iferi II, Akpan OE. The pattern of sale and use of non-steroidal anti-inflammatory drugs in rural and urban centers in Nigeria. Trop J Pharm Res. 2008;7(3):1013\u20138.","journal-title":"Trop J Pharm Res"},{"key":"1261_CR38","first-page":"245","volume":"8","author":"PO Nwani","year":"2017","unstructured":"Nwani PO, Isah AO. Frequency and patterns of adverse drug reactions among elderly in-patients in a Nigerian teaching hospital. J Basic Clin Pharm. 2017;8:245\u201350.","journal-title":"J Basic Clin Pharm"},{"key":"1261_CR39","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/j.1365-2036.2008.03821.x","volume":"28","author":"P Ruszniewski","year":"2008","unstructured":"Ruszniewski P, Soufflet C, Barthelemy P. Non-steroidal anti-inflammatory drug use as a risk factor for gastroesophageal reflux disease: an observational study. Aliment Pharmacol Ther. 2008;28:1134\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"1261_CR40","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1023\/A:1013010616496","volume":"18","author":"J Kotzan","year":"2001","unstructured":"Kotzan J, Wade W, Yu HH. Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population. Pharm Res. 2001;18:1367\u201372.","journal-title":"Pharm Res"},{"issue":"Suppl.6","key":"1261_CR41","first-page":"A15","volume":"52","author":"RF Harvey","year":"2003","unstructured":"Harvey RF, McCune A, Lane A, et al. Effect of NSAIDs and aspirin on heartburn and gastroesophageal reflux in the community: the Bristol helicobacter project. Gut. 2003;52(Suppl.6):A15.","journal-title":"Gut"},{"issue":"1","key":"1261_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1586\/egh.12.61","volume":"7","author":"C Martin-de-Argila","year":"2013","unstructured":"Martin-de-Argila C, Martinez-Jimenez P. Epidemiological study on the incidence of gastroesophageal reflux disease symptoms in patients in acute treatment with NSAIDs. Expert Rev Gastroenterol Hepatol. 2013;7(1):27\u201333.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"2","key":"1261_CR43","first-page":"366","volume":"21","author":"A Sosal","year":"2019","unstructured":"Sosal A, Saglan R, Zencirci SA, Saglan Y, Tirpan K, Arslantas D, Unsal A. Evaluation of gastroesophageal reflux disease and variables related with its severity in adults. Progress Nitrition. 2019;21(2):366\u201374.","journal-title":"Progress Nitrition"},{"issue":"2","key":"1261_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/dote.12310","volume":"29","author":"S Bor","year":"2016","unstructured":"Bor S, Lazebnik L, Kitapcioglu G, Manannikof I, Vasiliev Y. Prevalence af gastroesophageal reflux disease in Moscow. Dis Esophagus. 2016;29(2):159\u201365.","journal-title":"Dis Esophagus"},{"key":"1261_CR45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1472-6882-11-117","volume":"11","author":"IA Oreagba","year":"2011","unstructured":"Oreagba IA, Oshinkoya KA, Amachree M. Herbal medicine use among urban residents in Lagos, Nigeria. BMC Complement Alter Med. 2011;11:117.","journal-title":"BMC Complement Alter Med"},{"key":"1261_CR46","doi-asserted-by":"publisher","unstructured":"Shu EN, Onyemelukwe NF, Nwodo ES, Otuu FC, Ilouno L. Unwholesome herbal medicines marketed in Enugu metropolis, Enugu State, South Eastern Nigeria: Public health implications. J Environ Sci Public Health. 2019;3:122\u201332. https:\/\/doi.org\/10.26502\/jesph.96120053.","DOI":"10.26502\/jesph.96120053"},{"key":"1261_CR47","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1136\/gut.19.4.336","volume":"19","author":"SE Kaufman","year":"1978","unstructured":"Kaufman SE, Kaye MD. Induction of gastroesophageal reflux by alcohol. Gut. 1978;19:336\u20138.","journal-title":"Gut"},{"issue":"6","key":"1261_CR48","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1631\/jzus.B1000013","volume":"11","author":"S Chen","year":"2010","unstructured":"Chen S, Wang J, Li Y. Is alcohol consumption associated with gastroesophageal reflux disease? J Zhejiang Univ Sci B. 2010;11(6):423\u20138.","journal-title":"J Zhejiang Univ Sci B"},{"key":"1261_CR49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cgh.2017.07.041","volume":"16","author":"LH Eusebi","year":"2018","unstructured":"Eusebi LH, Ratnakumaran R, Bazzoli F, Ford AC. Prevalence of dyspepsia in individuals with gastroesophageal reflux-type symptoms in the community: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16:39\u201348.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1261_CR50","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","volume":"150","author":"DA Drossman","year":"2016","unstructured":"Drossman DA, Hasler WL. Rome IV functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016;150:1257\u201361.","journal-title":"Gastroenterology"},{"key":"1261_CR51","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/j.1365-2982.2006.00811.x","volume":"18","author":"S Gonlachavit","year":"2006","unstructured":"Gonlachavit S, Maurer AH, Fisher RS, Parkman HP. Regional gastric emptying abnormalities in functional dyspepsia and gastroesophageal reflux disease. Neurogastroenterol Motil. 2006;18:894\u2013904.","journal-title":"Neurogastroenterol Motil"},{"key":"1261_CR52","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrgastro.2012.253","volume":"10","author":"EM Quigley","year":"2013","unstructured":"Quigley EM, Lacy BE. Overlap of functional dyspepsia and GERD-diagnostic and treatment implications. Nat Rev Gastroenterol Hepatol. 2013;10:175\u201386.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1261_CR53","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s10620-017-4455-8","volume":"62","author":"CS Hsu","year":"2017","unstructured":"Hsu CS, Wen SH, Hung JS, Liu TT, Yi CH, Lei WY, et al. Overlap of dyspepsia in patients with gastroesophageal reflux disease: impact of clinical, metabolic and psychosocial characteristics. Dig Dis Sci. 2017;62:994\u20131001.","journal-title":"Dig Dis Sci"},{"key":"1261_CR54","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1136\/gut.2008.175810","volume":"58","author":"E Savarino","year":"2009","unstructured":"Savarino E, Pohl D, Zentilin P, Dulbecco P, Sammito G, Sconfienza L, et al. Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut. 2009;58:1185\u201391.","journal-title":"Gut"},{"key":"1261_CR55","doi-asserted-by":"crossref","unstructured":"de Bortoli N, Frazzoni L, Savarino EV, Frazzoni M, Martinucci I, Jania A, et al. Functional heartburn overlaps with irritable bowel syndrome more often than GERD. Am J Gastroenterol. 2016;111:1711\u20137.","DOI":"10.1038\/ajg.2016.432"},{"key":"1261_CR56","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1159\/000431370","volume":"24","author":"SW Lee","year":"2015","unstructured":"Lee SW, Chang CS, Lien HC, Peng YC, Wu CY, Yeh HZ. Impact of overlapping functional gastrointestinal disorders on the presentation and quality of life of patients with erosive esophagitis and non-erosive reflux disease. Med Princ Pract. 2015;24:491\u20135.","journal-title":"Med Princ Pract"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01261-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-020-01261-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01261-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T23:52:35Z","timestamp":1618444355000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-020-01261-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,15]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1261"],"URL":"https:\/\/doi.org\/10.1186\/s12876-020-01261-8","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,15]]},"assertion":[{"value":"1 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was submitted to and approved by the University of Nigeria Teaching Hospital Research Ethics Committee. All study participants gave written informed consent before being recruited.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}